HMB-synthase; formerly known as porphobilinogen deaminase or utoporphyrinogen I synthase). Clinical onset of AIP typically occurs during or after puberty and is characterized by acute attacks of neurologic dysfunction. These attacks include abdominal pain, hypertension, tachycardia, and various peripheral and central nervous system manifestations. The attacks are precipitated by environmental (e.g., certain drugs, dieting, or starvation), metabolic (e.g., alcohol), and hormonal (e.g., certain steroids) factors that induce hepatic S-aminolevulinic acid synthase activity, the first and rate-limiting enzyme of heme bi0synthesis.l-' With increased activity of this enzyme, levels of the porphpin precursors, 5-aminolevulinic acid (ALA) and porphobilinogen (PBG} increase, and the halfnormal level of hepatic EIMB-synthase activity in AIP patients is insufficient to prevent pathologic accumulation of these compounds, and acute, life-threatening neurologic symptoms. Presyrnptornatic identification of heterozygotes in affected families, and counseling regarding the avoidance of the precipitating factors is crucial in the management of this disease. Symptomatic heterozygotes, who excrete increased urinary levels of A m and PBG, are easily identified, provided that the diagnosis is considered. In contrast, the diagnosis of asymptomatic heterozygotes (-80% of heterozygous individuals), who usually have normal levels of urinary A M and PBG, has been problematic primarily due to the significant overlap between high heterozygote and low normal values of HMBsynthase activity in Therefore, efforts have been directed to identify the specific HMB-synthase mutations in each family, particularly because most mutations have been "private," i.e., limited to a single or few families.
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HMB-synthase is a monomeric enzyme that catalyzes the head to tail condensation of four molecules of PBG to form the linear tetrapyrrole hydroxymethylbilane.l.2 HMB-synthase is encoded by a single 1 1-kb gene that contains 15 exons and 2 distinct promoters that generate housekeeping and erythroidspecific transcripts by alternative spli~irig.'~-'~ The housekeeping promoter is in the 5' flanking region and its transcript contains exons 1 and 3-1 5, whereas the erythroid-specific promoter is in intron 1 and its transcript is encoded by exons [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . The hausekeeping and erythroid-specific transcripts encode isozymes of 42 and 40 m a , respectively.ll In classic RIP (-95% of the AIP families), both the housekeeping and erythroid-specific isozymes have half-normal activities, whereas in variant AIP (representing -5% of AIP families), the house-keeping enzyme has half-normal activity, while the erythroidspecific enzyme is expressed at normal levels.I4 The availability of the full-length cDNA and complete genomic sequences encoding human HMB-synthase permits the identification of the specific lesions in the gene that cause ~1 p . l o -l~ TO date, over 160 mutations causing AIP have been identified;15-I' approximately 50% are point mutations and the rest, splice site mutations, insertions, and deletions. The absence of "common" AIP mutations necessitates identification of the disease causing lesions in each AIP family for accurate presymptomatic diagnosis. In this communication, five HMB-synthase mutations are described, two newly discovered missense mutations in exon 6 (T78P and ESOG), and three previously reported mutations, IVSl + ', G l 1 lR and R173W. Of note, identification of the E80G mutation in members of a previously reported family diagnosed by enzyme assay clarified the genotypic status of at-risk member^.^
Patient specimens
Peripheral blood samples were collected from members of five unrelated AIP families of Northern European ancestry with informed consent. Proband 1 and his family were previously described by Bottomley et al." Genomic DNA was extracted from peripheral blood using the Puregene DNA isolation kit [Gentra Systems, Inc. Minneapolis, MN].
Long-range PCR
Long-range PCR was performed using two primer sets to amplify the entire HMB-synthase gene (1 1 kb) in two fragments, a 4.5-kb product which included the promoter region through intron 3 and a 5.5 kb product which contained exon 2 through exon 15.18 Using the GeneAmp XL PCR Kit (Perkin Elmer, Foster City, CA) and a PCR Minicycler (M.J. Research, Watertown, MA), an initial incubation was performed at 94OC for 1 minute, and then fragments 1 and/or 2 were amplified from genomic DNA in a single or separate reaction(s). The first 16 cycles were performed with denaturation at 94OC for 30 seconds and annealing and extension at 65OC for 6 minutes. The second 12 cycles were carried out with denaturation at 94°C for 30 seconds, and annealing and extension at 65OC for 375 seconds, with 15 seconds increments each additional cycle. The final extension step was performed at 72OC for 10 minutes. A portion of each PCR product was analyzed by agarose gel electrophoresis to confirm that the long-range reactions were successful, and to identify any gross gene rearrangements. Each PCR product was purified with the High Pure PCR Product Purification Kit (Boehringer Mannheim Corp., Indianapolis, IN).
Sequencing reactions
Each exon and flanking intronic regions was sequenced using the Amplicycle Sequencing Kit (Perkin-Elmer), according to the manufacturer's instructions with the following modifications. The sense and antisense primers used for sequencing each exon are listed in De Siervi et a1.I8 To a set of four tubes, each containing 2 pL of one of the dNTPs, 6 pL of the following mixture was added: 4 pL of cycling mix ( 1.25 U of Amplitaq DNA polymerase in 500 mM Tris-HC1, pH 8.9; 100 mM KC1; 25nM MgC1,; 0.25% Tween 20), 1 pL ofprimer (20 pM); 1 pL of DNA (100 ng); 23 pL of H,O and 1 p~ of [ C X -~~P ] dATP (1 pCi, Dupont). After adding one drop of mineral oil, the tubes were placed in the PCR machine (M.J. Research, Watertown, MA) and preheated at 95OC for 3 minutes. The cycle sequencing reaction was performed (30 cycles) with a denaturation step at 95OC for 30 seconds, annealing at 60°C for 30 seconds, and extenuation at 72OC for 60 seconds. The reaction was stopped by adding 4.5 pL of stop solution (95% formamide; 20 mM EDTA; 0.05% bromophenol blue and 0.02% xylene cyanol). After a denaturation step of 3 minutes at 94OC, the samples were loaded in a 4% acrylamide solution (19:l) containing 7 M urea gel, preheated at about 50°C, and electrophoresed at 90 W for different times, depending on both the region being sequenced and the primer used. When the run was completed, the gel was transferred to a filter paper (Whatman No. 3) with a plastic film, dried for 2 hours at 80-90°C, and exposed to autoradiographic film (Kodak X-OMAT) for 48 hours.
Dot blot hybridization
Amplified DNAs from exon 6 of the proband and members ofFamily 3 were slot-blotted on Hybond N + nylon membrane and then hybridized to allele-specific oligonucleotides (normal allele: 5'-AGACCTAGCA-TACTAGGG-3'; mutant allele: 5'-GCCTCTGTCCCCATCATGAA-3') using the following conditions: 3-5 mL of Amersham Rapid Hybridization solution was added to a sealable bag, and the pouch was prehybridized for 30 minutes at 42OC in a shaking water bath. The [~-P~~]~A T P labeled probe was added to the pouch at a concentration of 1-2 X lo6 cpm per mL of hybridization solution and replaced in the shaking water bath for 60 minutes at 42OC. The membrane was removed from the bag and washed at room temperature for 10 minutes in 6 X SSC and a second time for 10 minutes at 42OC. The membrane was washed for a third time in 0.5 X SSC/O.l% SDS for 10 minutes at 42OC. The membrane was covered with polyvinylchloride wrap and exposed to x-ray film for 3 hours.
Prokawotic expression of the missense mutations
The normal, T78P and E80G HMB-synthase alleles were individually expressed in E. coli using the pKK233-2 vector (Pharmacia Biotech., Inc., Piscataway, NJ) as previously described.I8,l9 To introduce the mutations into the normal pKK-HMB-synthase (pKK-HMBS) expression construct, the QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA) was used according to manufacturer's directions. For the T78P and E80G mutations, sense and antisense primers, 5'-GGAGAGAAAAGC-CTGTTTCCCAAGGAGCTTGAACATGC-3' and 5'-GCATGT-TCAAG-CTCCTTGGGAAACAGGCTTTTCTCTCC-3' and sense and antisense primers, 5'-GGAGAGAAAAGCCTGTT-TAC-CAAGGGGCTTGAACATGC-3' and 5'-GCATGTTC-AAGCCCCTTGGTAAACAGGCTTTTCTCTCC-3' were used, respectively. The mutant pKK233-2 vectors were sequenced before the expression studies to ensure that each contained the indicated mutation. After transfection, bacterial growth, and isopropylthiogalactoside (IPTG) induction, the expressed HMBsynthase activity was assayed as previously described.I3.l9
RESULTS
Direct solid-phase sequencing of the HMB-synthase gene from five unrelated AIP probands previously diagnosed biochemically (Table 1) identified two new missense mutations and three previously reported lesions ( Table 2 ). All five mutations were initially identified by sequencing the entire exonic region and adjacent intronic and flanking sequences; no other alterations were identified. Each mutation was detected in other, at risk family members, consistent with the expression and/or inheritance of this autosomal dominant acute porphyria. The mutations were confirmed by repeat direct sequencing of genomic DNAs from the proband and/or symptomatic and asymptomatic family members. The two novel mutations are only the second and third mutations identified in exon 6: an adenine to cytosine transversion at cDNA nucleotide (nt) 232, which predicted the replacement of an uncharged polar threonine by a hydrophobic nonpolar proline, T78P (Fig. la) , and an adenine to guanine transition at cDNA nt 239, which predicted the substitution of a hydrophilic polar glutamic acid by an uncharged polar glycine, E80G (Fig. lb) . To further characterize these base substitutions, pKK-HMB-synthase expression vectors containing either the T78P or the E80G mutations were constructed, expressed in E. coli, and the enzymatic activity of the mutant proteins was determined. As shown in Table  3 , the residual enzymatic activity of the mutant T78P protein was 2.5% of the mean enzymatic activity expressed by the normal allele, whereas the mutant E80G protein was 2.4%. That both mutations had markedly decreased HMB-synthase activity confirmed that they were pathogenic lesions.
The three previously reported mutations included an adenine to cytosine transversion at cDNA nt 100 in exon 4, which predicted the replacement of a glutamine by a hydrophilic po- lar arginine, G11 lR9,'k20; a cytosine to thymidine transition of a CpG dinucleotide at cDNA nt 517 in exon 10, which predicted the substitution of a hydrophilic polar arginine by a hydrophobic nonpolar tryptophan, R173W'l; and an IVSl+'; a guanine to adenine transition, which altered the invariant 5' donor splice site of intron 1 from gt to at." The IVS+' mutation was detected in proband 5 who had normal erythrocyte HMB-synthase activity, but was diagnosed as having AIP on the basis of her symptoms and increased urinary porphobilinogen. The detection of the I V S~+ ' mutation identified the proband as having variant AIP. Molecular diagnostic studies of the proband's two offspring indicated that neither daughter had inherited the IVSl+' mutation (Fig. 2) . The G111R lesion was detected only in the proband of Family 3. The R173W mutation in Family 4 was also identified in the proband's daughter.
The E80G mutation was identified in a large kindred in which Proband 2, his five siblings, and some of their children were previously evaluated for AIP by their erythrocyte HMBsynthase enzymatic activities or increased urinary PBG excreti0n.l As shown in Figure 3 , available family members were tested for the E80G mutation by dot-blot hybridization with allele specific oligonucleotides. DNA testing confirmed the enzyme-based diagnosis of those who previously had normal or low erythrocyte HMB-synthase. In addition, the two family members who were inconclusive by enzyme assay did not have the mutation.
DISCUSSION
For many genetic disorders, the presymptomatic diagnosis of affected individuals as well as the identification of carriers of recessive genes has been remarkably improved by DNA analyses. Such is the case for AIP, where the biochemical demonstration of the enzymatic deficiency has proven pr~blematic.-'-~ In asymptomatic heterozygotes with classic AIP who have half normal levels of erythrocyte HMB-synthase activity, the enzymatic diagnosis has been difficult due to significant overlap between low normal and high heterozygote values. In asymptomatic patients with variant AIP, the enzymatic diagnosis is not possible because they have normal erythrocyte HMB-synthase activity, although the levels in liver and other tissues are half-normal.14 Therefore, the identification of mutations causing the classic form, and especially the variant form of AIP, is critical for precise diagnosis and appropriate counseling of affected individuals.
Because sequencing of the HMB-synthase gene in each AIP family is labor-intensive and expensive, initial efforts focused on the identification of informative intragenic polymorphism~, which could identify heterozygotes by pedigree analysis.13 However, most of the intragenic polymorphisms were in linkage disequilibrium and others were less frequent, thereby limiting or precluding the use of this approach for most AIP families. TO date, common mutations have been identified only in a few ethnic or demographic groups; these include Swedish (W198X),'3 Dutch (R116W),'hnd Argentinean (G11 1R)IR AIP families, each of which presumably had a common founder. Thus, the precise diagnosis of AIP heterozygotes requires the identification of the specific HMB-synthase lesions in each family. Of the five mutations identified in this study, T78P and E80G were novel missense mutations that both occurred in exon 6, seven nucleotides apart. These are only the second and third mutations to be identified in exon 6 and both involve highly conserved amino acids. Threonine-78 was found in 11 of 19 HMB-synthase orthologues with valine present in the other eight, while glutamic acid-80 was conserved in 17 of 19 orthologues. The E. coli HMB-synthase crystal structure, which has been solved at 1.76 A r e s o l u t i~n ,~~ had three domains, each containing P-sheets, a-helices, and a discrete hydrophobic core, with mainly polar contacts between the dom a i n~.~~-? '
Because there is 35% homology and > 70% similarity between the predicted E. coli and human amino acid sequences, structure/function relationships can be inferred for certain human m~t a t i o n s .~~,~~ Molecular modeling of the T78P and E80G lesions revealed that the T78P mutation occurred at a p-turn just before the second a-helix of domain 1, while the E80G substitution was within the a-helix. The T78P and G80G lesions are both predicted to effect the stability, if not the formation, of this short, eight residue a-helix. The T78P mutation would be expected to alter the formation of the helix, and possibly exist in conformational heterogeneity between the cis and trans forms, thereby altering the subtype of the p-turn before the start of the helix. The E80G mutation would disrupt the middle of the first turn of this two turn helix as predicted by the low probability of glycine existing in an a-helical conformation. That these missense mutations would alter the enzyme structure and stability is consistent with the finding that both expressed mutations had markedly decreased activities.
Two of the previously described mutations, GI1 lR,y,lfi~~O and R173W," caused classic disease, whereas the I V S l + ' " lesion occurred in a variant AIP patient. The R173W lesion occurred at a CpG dinucleotide, a known hot spot for muta- tions due to the deamination of methylcytosine to thymidine.'"n fact, 26% of the reported HMB-synthase single base substitutions involve exonic CpG dinucleotides,17 indicating that these dinucleotides are frequent sites in the HMB-synthase gene for mutations causing AIP. The G l l lR mutation, detected in Family 3, which had French ancestry, was previously identified in AIP patients from Belgium,'" France," and, most recently, in Argentinean AIP patients of European descent.lx In classic AIP families, identification of the specific causative mutations permits the precise diagnosis of heterozygotes who can be counseled to avoid the factors that precipitate acute attacks. Enzyme diagnosed individuals may be reassessed to clarify a borderline enzyme result or to confirm previous diagnoses. The identification of the E80G mutation in Family 2 from a large previously studied AIP family confirmed the earlier enzyme diagnoses of the eight family members available for our studies."f note, a niece of proband 2 had erythrocyte HMB-synthase activity in the inconclusive range and thus was thought to be a risk for AIP.4 However, mutation analysis revealed that her mother did not have the E80G mutation, thus clarifying the niece's genotype.
As noted above, the enzymatic diagnosis of families with variant AIP is not possible as they have normal erythrocyte HMB-synthase activity as exemplified by the proband from Fanlily 5. The identification of the IVS1" mutationx in this family permitted the n~olecular diagnosis of the proband's daughters, neither of whom inherited the IVSl+' mutation (Fig. 2) . The 1VSlt1 5' donor splice site mutation was previously reported in one unrelated AIP family.' To date, six other mutations causing variant AIP have been identified, five splice site lesions ( I V S~~' . ' Y I v S~-~,~O IVSl+',31 IVS1'7,30 and IVSl+""), which like the I V S l f 1 mutation result in an abnormal housekeeping transcript and no housekeeping enzyme, and an alteration of the initiation ATG in exon 1, which precludes normal translation of the housekeeping isozyme.Iv In summary, two new mutations and three previously reported mutations causing AIP were identified in probands from five unrelated AIP families. Identification of these mutations highlights the n~olecular heterogeneity underlying AIP, permits the precise diagnosis of asymptomatic heterozygotes in these AIP families, and provides information for future structure-function studies of the human enzyme.
